Experience

Nordic Bioscience

• Denmark
• Biotechnology Research
• 100 - 200 Employee

• Chief Laboratory Officer (CLO), Head of Clinical Laboratory

  • Jun 2021 - Present

  Responsible for the overall operation and administration of laboratory services and to ensure that business objectives are met efficiently and effectively.- Manage laboratory services under GCP/GCLP regulation and CAP accreditation- Biochemical markers validations in accordance with CLSI and EMA guidelines- Interact closely with pharmaceutical companies/clients for plan, execute and monitor projects- Internal lead for external audits- Digitalization and automation of laboratory operations- Contribute to corporate strategy in the area of Laboratory services to ensure that short and long-term objectives are achieved - Manager of 60 employees and several cross-functional teams Show less

• Principal investigator - Biochemical marker research in hemophilic arthropathy

  • Nov 2013 - Dec 2022

  - leading the biomarker efforts in hemophilia- designing and developing novel biomarkers quantifying disease-specific protein fragments of hemostasis and wound healing

• Director, Production and Compliance

  • Sep 2019 - May 2021

  - Produce and validate biochemical markers under GMP and in accordance with CLSI and EMA guidelines- QA Manager for the bioanalytical laboratory under GCP/GCLP regulation and CAP accreditation standards- Internal lead for external audits by sponsor, BUREAU VERITAS, arbejdstilsynet, Herlev kommune - Manager of 28 employees and several cross-functional teams

• Director of Gastroenterology and Antibody Research

  • Jan 2018 - Sep 2019

  - designing and developing monoclonal neo-specific antibodies using the hydridoma technology- designing, developing, patenting and publishing enzyme-linked immunosorbent assays (ELISAs) for quantifying disease-specific protein fragments, as diagnostic and prognostic biomarkers of hemophilia, inflammatory bowel disease and fibrotic diseases- drive the biomarker efforts in inflammatory bowel disease and hemophilia - traveling and interacting closely with pharmaceutical companies discussing biomarker validation in clinical cohorts and interpretation of results- department manager for 11-13 people including senior scientist, laboratory technicians, PhD students and master students- privacy officer and contact to data protection officer (DPO) Show less

• Head of Antibody Research

  • Mar 2014 - Jan 2018

  - Designing and developing monoclonale neo-specific antibodies using the hydridoma technology.- Developing, patenting and publishing enzyme-linked immunosorbent assays (ELISAs) for quantifying disease-specific protein fragments, as diagnostic and prognostic biomarkers of hemophilia- Department manager for 8-10 people including a senior scientist, laboratory technicians, a PhD student and master students



Nuevolution A/S

• Denmark

• Patent assistant (part-time)

  • Aug 2009 - May 2015

  Review and approval of laboratory books (molecular biology and chemistry) Review and approval of laboratory books (molecular biology and chemistry)



Goethe University Frankfurt

• Germany
• Higher Education
• 700 & Above Employee

• Postdoc - proteoglycan research

  • Sep 2012 - Aug 2013

  Addressing the function of proteoglycans (syndecans, biglycan, decorin) in inflammatory diseases using transgenic mice. Also responsible for design and production of neutralizing antibodies against biglycan-mediated-TLRs signalling. Addressing the function of proteoglycans (syndecans, biglycan, decorin) in inflammatory diseases using transgenic mice. Also responsible for design and production of neutralizing antibodies against biglycan-mediated-TLRs signalling.



Biotech Research & Innovation Centre (BRIC), University of Copenhagen

• Denmark
• Biotechnology Research
• 100 - 200 Employee

• Ph.D. student - proteoglycan research

  • May 2008 - Jan 2012

  Addressing important area of cell surface proteoglycan receptors research with relevance for tumour biology. This was done through analyze proteolytic cleavage products for syndecan-1 and syndecan-4, generating monoclonal antibodies that specifically recognize the cleavage product but not the core protein, and to use these antibodies to stain for specific syndecan cleavage products in tumour biopsies Addressing important area of cell surface proteoglycan receptors research with relevance for tumour biology. This was done through analyze proteolytic cleavage products for syndecan-1 and syndecan-4, generating monoclonal antibodies that specifically recognize the cleavage product but not the core protein, and to use these antibodies to stain for specific syndecan cleavage products in tumour biopsies



Novo Nordisk

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Master student - Diabetes biology

  • 2006 - 2007

  Inducible mammalian expression of insulin and IGF-1 receptors: effect of receptor dosage on insulin signalling Inducible mammalian expression of insulin and IGF-1 receptors: effect of receptor dosage on insulin signalling



Centre for Diagnostics - DTU Health Technology

• Hospitals and Health Care
• 1 - 100 Employee

• Laboratory technician

  • 2001 - 2002

  Involved mostly research, but also routine diagnostic work, training of colleagues, quality control, and preparing results from diagnostic testing. Involved mostly research, but also routine diagnostic work, training of colleagues, quality control, and preparing results from diagnostic testing.